Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Antidepressant Effects of Nitrous Oxide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the antidepressant effects of nitrous oxide in major depressive disorder and treatment-resistant depression is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrous oxide (nitrous oxide)

Snippet

Sponsor: University of Chicago | Conditions: Major Depressive Disorder, Treatment Resistant Depression | Phase 2 | Status: RECRUITING